Global Digital Store – Ebooks and Softwares

Tag: Therapy

Courses in Holistic Medicine

[ad_1]

Earn your professional diploma in the healing arts when you enroll in courses in holistic medicine. Among the subject matter in these holistic medicine programs are in-depth studies in anatomy and physiology, pathology and disease, detoxification methods, energy healing, herbal medicine (both Eastern and Western modalities), homeopathy, orthomolecular nutrition/holistic nutrition, flower essences and remedies, holistic counseling, iridology, and other natural medicine.

There are also courses in holistic medicine that are both degreed and non-degreed. For those seeking a more comprehensive natural healing career, degreed courses in holistic medicine are the best options. In addition to gaining a four-year Naturopathic Medical Degree (N.D.), there are other academic routes that can be taken like programs that offer Doctorate degrees in chiropractic, herbal medicine, and acupuncture and Oriental medicine, among others.

Before applying to any holistic medicine programs, it is important to determine which prerequisites are necessary for enrollment. In many cases, degree courses in holistic medicine often require a standard education in a variety of studies including biology, chemistry, English, humanities, physics, and psychology.

Non-degree courses in holistic medicine are also available to professionals who want to brush up skills through continuing education, or for those who would like an introduction to the wide array of natural health programs. Today, there are a number of natural healing schools that provide basic holistic workshops and seminars to the general public; which may include beginner classes in self-massage, home herbal remedies, holistic nutrition (including vitamins and supplements), iridology, reflexology, and other natural health specialties.

If you (or someone you know) are interested in learning more about these or other healing arts programs, let professional training within fast-growing industries like massage therapy, naturopathy, acupuncture, Chinese medicine, Reiki, and others get you started! Explore courses in holistic medicine near you.

[ad_2]

Source by CarolAnn Bailey-Lloyd

Views: 1

November 11, 2022
Oxygen Therapy – Is This a Cure For Herpes?
[ad_1]

Since anaerobic viruses cannot survive in an oxygen rich cellular environment, one would think that the herpes simplex virus could be eliminated via oxygen therapy.

Unfortunately this is not so easy, and here’s why:
- The primary function of the lungs is to oxygenate red blood cells.
- Inhaled oxygen is taken up by red cell hemoglobin, thereby boosting the oxygen content of arterial blood to 98%.
- While circulating, arterial blood gives up about 25% of its oxygen when passing through bodily tissue.
- A tiny proportion of these oxygen atoms actually penetrate down to cellular level where the herpes virus replicates – the balance is used for waste disposal and tissue repair.
- As a result, the hemoglobin of venous blood leaving the tissues is oxygen-poor. If extra oxygen is infused by other means such as high-pressure hyperbaric oxygen therapy or via oral supplements, it bypasses bodily tissue and is absorbed directly into venous blood.
This means that when venous blood arrives back at the lungs, it carries more oxygen than it usually does. Once the oxygen level in the red cell hemoglobin reaches 98% during lung function, the excess oxygen is simply exhaled back into the atmosphere.

This makes it impossible for extra infusion to increase the amount of oxygen carried to the tissues at cellular level.

How Can We Increase The Oxygen Content of Human Cells?
- Since oxygen depletion at cellular level is exacerbated under acidic conditions, a practical way of boosting cellular oxygen is to alkalize the body.
- Alternatively, a means of improving cellular oxygen absorption must be developed.
A motivated homeopathic researcher and herpes victim may have found a way of doing just that.

I recently came across her e-book via twitter. I also noticed that news of a possible herpes cure was beginning to gain media attention.

However, knowing the obstacles facing researchers attempting to cure herpes by oxygenating human cells, I almost passed the book by. Nevertheless, because I am obligated to bring relevant information to my website visitors, I downloaded the book.

Here’s what I found out:

Apparently the author has discovered a way to use a common substance to efficiently boost the transference of oxygenated atoms from the bloodstream into human cells.

In her book she says:

“The only reason why the medical industry and the pharmaceutical companies haven’t embraced this powerful solution for preventing and curing disease is because there is no financial incentive to do so. The reason? They cannot patent natural substances or homeopathic remedies.”

The e-book starts out by covering herpes basics. The author then gets down to the business of oxygen therapy.

She tells us how oxygen therapy research earned a Nobel Prize for an early 20th century scientist and that oxygen therapy is practiced to this day in some modern medical offices.

And then she drops the bombshell.

Effective oxygen therapy has been proved to work with the help of a common household substance. Furthermore, this substance can be obtained easily via pharmacies or over the Internet.

After reading the publication and checking out some testimonials, I’ve come to the conclusion that this may well be the answer many herpes sufferers are looking for…

That is, if her claims prove to be true.

Should you read the book?

Well, that’s up to you. However, since there’s no obligation to buy, I believe the preliminary information is certainly worth a closer look.

[ad_2]

Source by Ian R Kelly

Views: 0
November 11, 2022
Maternal infections in health facilities

A clearer picture of the global impact

New research from the Global Maternal Sepsis Study (GLOSS), a major WHO/HRP initiative, shows that infection has a much larger impact on global maternal mortality and morbidity than previously thought.

The
results from GLOSS, published in The Lancet Global Health, are the first to provide data on frequency of maternal infections and
sepsis across the pregnancy and post-pregnancy period, in a large number of health facilities around the world.

Around 11 women per 1000 live births had an infection which resulted in or contributed to what is known as a severe maternal outcome – either they died or nearly died – during their hospitalization.

Urgent improvement is needed to manage this life-threatening risk faced by all pregnant and recently pregnant women, wherever they are in the world.

What is maternal sepsis and how does it lead to maternal death?

Maternal sepsis is a life-threatening condition that arises when the body’s response to infection causes injury to its own tissues and organs during pregnancy, child-birth, post-abortion or the postpartum period.

The latest global estimates place sepsis due to obstetric infections as the third most common cause of maternal mortality. However, this only includes infections as a direct result of pregnancy, such as endometritis or post-caesarean wound infections.

Few
previous studies include post-abortion infections. Neither do they address indirect infections such as respiratory and meningitis, which are aggravated by pregnancy but not directly caused by it.

A better understanding of maternal infection

GLOSS was a massive facility-based data collection effort led by WHO, accompanied by a ‘STOP SEPSIS!’ campaign to increase awareness among healthcare providers.

The study gathered data on women who were admitted with suspected or confirmed infection during pregnancy or post-pregnancy over a one-week period in 2017. More than 2800 women participated in the study in 52 countries.

GLOSS included healthcare facilities that care for women during pregnancy, childbirth or at the end of pregnancy, as well as facilities without maternity service but where women could be hospitalized during or after pregnancy, and data on infections
which are not usually recorded as maternal sepsis, including post-abortion and indirect infections.

The result is a more complete understanding of the frequency and impact of maternal infections in health facilities.

GLOSS calls attention not only to the wider range of risks faced by pregnant women but also to the long period of time during which they are at risk.

Putting global numbers on maternal infection and sepsis

Overall, around 70 pregnant or recently-pregnant women per 1000 live births were found to have a maternal infection needing hospital management.

Across the study, 11 women with either direct or indirect infection per 1000 live births developed a severe maternal outcome, but in low- and middle-income countries up to 15 women per 1000 births were affected.

Infections were the underlying cause of most of the deaths recorded during the study, primarily post-abortion infection and indirect infections. Infections were also present in about a third of deaths attributed to other causes, such as postpartum
haemorrhage.

This suggests that the contribution of infection to global maternal mortality and morbidity may be larger than current reports of maternal sepsis mortality suggest.

Preventing, identifying and treating maternal infection and sepsis

Some of the most common maternal infections found in the study, such as urinary tract infections, post-caesarean and post-abortion infections, are largely preventable and treatable.

GLOSS results suggest that current levels of monitoring and clinical care across health facilities are not enough to prevent, identify and treat levels of maternal infection effectively.

For instance, a complete set of vital signs was not reported for a third of the women in the study, on the day their infection was suspected or diagnosed. Delays in antimicrobial therapy were frequent.

GLOSS also shows marked differences across countries, with the highest burden in low- and middle-income countries, compared with high-income countries.

This may reflect the impact of broader health determinants in different country contexts. Challenges of overcrowding, limited access to water and sanitation and constraints to safe births by skilled birth attendants can reduce the ability of healthcare
providers to manage the frequency and outcome of maternal infections.

An opportunity to implement evidence-based practice

GLOSS gives healthcare providers, policy-makers, and the public at large an opportunity: to mobilise around these data improve evidence-based practice, and save lives.

WHO has produced a number of resources which can support timely action to prevent, diagnose and treat maternal infection, as well as activities such as the upcoming SAVE LIVES: Clean Your Hands campaign
on 5 May which celebrates the central role played by nurses and midwives in clean health care.

In addition, WHO will publish a global sepsis epidemiology report around the 73rd World Health Assembly (WHA) in May, as requested in the
2017
WHA Resolution on Improving the prevention, diagnosis and clinical managementof sepsis.

Understanding why and how infection affects women is essential for equipping healthcare providers with life-saving knowledge and enabling health care systems to bring down global maternal mortality and morbidity.

Related publications

WHO recommendations for prevention and treatment of maternal peripartum infections

WHO Clinical practice handbook for safe abortion

Global guidelines on the prevention of surgical site infection

WHO statement on maternal sepsis

World Health Assembly resolution on Improving the prevention, diagnosis and clinical management of sepsis

Health Topics

Antimicrobial resistance

Infection Prevention and Control

Water Sanitation Hygiene

Other links

Global Maternal Sepsis Study

SAVE LIVES: Clean Your Hands 5 May 2020

Read More
https://www.who.int/news-room/detail/27-04-2020-maternal-infections-in-health-facilities

Views: 0

May 9, 2020
Breakdown of Funds Donated to Federal and State Governments in the Fight Against the Coronavirus.

As the Nigerian Government intensifies efforts in its battle towards Coronavirus, monetary donations have continued to pour in from each sector to help the battle.

High-profile Nigerians and politicians have additionally donated mouth-watering sums to authorities at the federal and state ranges to fight the virus.

Others like ex-President Olusegun Obasanjo supplied properties to be used as isolation centres and well being supplies for therapy of contaminated circumstances.

In complete, 22 donors have supported the battle to eradicate the virus from the nation.

So far, each the federal and state governments have obtained the sum of N40,771,000,000 as donation to the venture.

In a breakdown of the funds, the federal authorities led the marketing campaign with a donation of N10bn grant to Lagos State and N5bn to the Nigerian Centre for Disease Control, the company main the battle towards the virus.

While Tony Elumelu of United Bank for Africa donated N5bn to the authorities, Keystone Bank, Segun Agbaje of Guaranty Trust Bank, and Jim Ovia of Zenith Bank donated N1bn every.

Noteworthy of the donation is the Nigerian National Petroleum Corporation that donated N11bn to the authorities.

The donation raised previous considerations on the non-remittance of full income by the NNPC to the Nigerian Government.

The desk beneath exhibits a full breakdown of funds donated to federal and state governments in the battle towards the virus.

Breakdown of Funds Donated to Federal and State Governments in the Fight Against the Coronavirus. by Sahara Reporters on Scribd

PUBLIC HEALTH

News

AddThis

:

Original Author

:

Saharareporters, New York

Disable ads

:

Read More
http://saharareporters.com/2020/03/30/breakdown-funds-donated-federal-and-state-governments-fight-against-coronavirus

Views: 0

April 5, 2020
All SARI patients will initially be treated as Covid-19 cases: Health DG

PUTRAJAYA: All Severe Acute Respiratory Infection (SARI) patients should be treated as Covid-19 circumstances till confirmed in any other case, mentioned Health director-general Datuk Dr Noor Hisham Abdullah (pix).

He mentioned 12 healthcare employees have been suspected of contracting Covid-19 after they have been contaminated whereas treating pneumonia or SARI patients.

“So protection is very important for us; our healthcare workers must take precaution … all the necessary precaution to avoid getting the infection (Covid-19),” he mentioned at a each day media briefing on Covid-19 right here right now.

Explaining additional, Noor Hisham mentioned any affected person who failed to present full info when looking for therapy may jeopardise the security of healthcare employees.

“If a patient comes to our hospital and clinic and hides some of the information … then you put the healthcare workers at risk (of being infected with Covid-19),” he mentioned.

He mentioned healthcare employees had been advised to deal with these having cough and chilly with signs of pneumonia as suspected Covid-19 circumstances till investigation confirmed in any other case. — Bernama

Read More
https://www.thesundaily.my/local/all-sari-patients-will-initially-be-treated-as-covid-19-cases-health-dg-MA2211691

Views: 0

April 4, 2020
Nigeria’s Unhealthy Healthcare In Eye Of Coronavirus By Runcie C.W. Chidebe

Coronavirus (COVID-19) is right here to show us a lesson; I hope we be taught. Nigeria’s healthcare is unhealthy. But as an alternative of fixing it our rulers have been busy flying up and down to profit from different nation’s productive well being system. With Coronavirus, actuality is upon us. No extra operating abroad for medical trip. Our rulers can’t journey to the United Kingdom, United States of America or India anymore for medical care. These nations are additionally hanging on their final breath, battling to outlive the COVID-19 pandemic.

In 2017, President Muhammadu Buhari spent 103 days in London receiving medical therapy for an undisclosed sickness, spending taxpayers’ cash as an alternative of investing within the nation’s healthcare. Thousands of Nigerians died in the identical interval from totally different sicknesses. More than 3,000 girls died of breast most cancers, greater than 2,000 girls died of cervical most cancers and greater than 1,500 males died of prostate most cancers, in line with World Health Organization (WHO) figures on annual most cancers mortality.

I had hoped that on his return to Nigeria, President Buhari would declare a state of emergency within the nation’s well being sector. Painfully, nothing of such occurred. Nigeria’s funds allocation to healthcare has remained lower than 5% of the whole funds for the previous 5 years. Simply put, in 2020 the federal authorities budgeted N2,000 (£4.2) for every Nigerian with a complete of N427.Three billion as funds allocation to the well being sector whereas the United Kingdom budgeted £2,159.6 for every citizen with a complete well being funds of £143.4billion. It is similar dismal story within the states throughout Nigeria. Healthcare isn’t a precedence. In some states in Nigeria, a hospital is a 20-minute boat journey and an hour-long automobile journey. Because many poor Nigerians don’t personal boats, a girl in labour may bleed to loss of life earlier than she reaches the hospital.

On March 22, 2018, Bill Gates, founding father of Microsoft and the Bill & Melinda Gates Foundation, criticized Nigerian authorities’s poor funding of healthcare within the nation. In his phrases, “One in three children is chronically malnourished.” This tragedy has large implications for the economic system. According to the World Bank, addressing the stunting disaster in Nigeria would add virtually $30 billion to Nigeria’s GDP. It is painful that regardless of Mr. Gates assertion, nothing has modified. Nigeria has remained one of many nations on this planet with the worst healthcare system with over 60 deaths per 1000 stay births. Nigeria has one of many worst most cancers survival charges on this planet, with solely 2 to three most cancers radiotherapy machines working at any time and fewer than 70 oncologists for a inhabitants of over 200 million.

COVID-19 is exposing the insensitivity of our leaders to issues that matter most to us. That Nigerians are disobeying the federal government’s security recommendation on COVID-19 is a transparent reflection of residents’ distrust for his or her leaders. Many Nigerians belief their non secular leaders greater than they belief our political leaders. Successive governments have failed the nation, and it doesn’t appear like factor will change anytime quickly.

Nigeria is a rustic the place our rulers make legal guidelines as we speak and break the identical legal guidelines tomorrow. The Nigeria Centre for Diseases Control (NCDC) adopted the World Health Organization (WHO) guideline and strongly inspired all Nigerians coming from sure nations to self-isolate and monitor themselves, as a method to comprise or to delay the unfold of COVID-19. The president’s Chief of Staff, Abba Kyari, returned from Germany and as an alternative of isolating himself he was leaping from one state to a different, attending occasions and conferences with totally different folks, breaching the federal government’s personal advice and inserting the lives of different Nigerians in danger!

Now that COVID-19 is in Nigeria we have to face it with all that we’ve. But can we? The Nigeria Centre for Disease Control (NCDC) is now the nation’s solely perceived hope. Many Nigerians have been calling NCDC scorching traces, criticizing NCDC for not testing sufficient folks. But we must always face the music and never the dancer. NCDC is crippled and never effectively outfitted to guard Nigerians from the illness.

In 2016, NCDC budgeted N3.7m for its recurrent and N248m for capital allocations. That is a complete of N251.7m. Out of this, solely N155m was launched to the centre. In the identical 12 months, 1,166 Nigerians died of Cerebrospinal Meningitis. In 2017, the NCDC had a funds of N1.5b. Only N782m was launched. In the identical 12 months, greater than 120 Nigerians contracted Monkeypox and 7 folks died from the illness. That identical 12 months, the Presidency budgeted N77m for Aso Rock lease, N1b for journeys and sitting allowances, and N94m for meals. In 2018, the NCDC had a funds of N1.9b. Only N654m was launched. In the identical 12 months, N7.2b was proposed for Presidential Air Fleet. N440m was proposed for necessary improve and set up of stay TV and web service within the presidential aircrafts, N375m for brand spanking new cabin administration, N418m for the touchdown gears. In whole, over N1b was budgeted for the presidential aircrafts which is used for medical tourism and frequent journeys overseas.

On November 12, 2018, the NCDC institution invoice was signed by President Muhammadu Buhari, because of the efforts of Senator Mao Ohuabunwa, the then Chair, Senate Committee on Primary Healthcare and Communicable Diseases. On this premise, the NCDC was empowered with a laws for its work in stopping and making ready for outbreaks of infectious illnesses. Interestingly, the NCDC acquired the worst funds in 2019, the 12 months following the passage of the NCDC Act. The Centre had a funds of N1.4b, however solely N224m was launched. In the identical 12 months, over 472 Nigerians have been identified with Lassa fever and over 110 folks died from this viral hemorrhagic fever. Clearly, NCDC can’t carry out magic. They need assistance. Nigeria is grossly under-testing for COVID-19, the laboratories usually are not sufficient, and NCDC and its affiliate businesses wouldn’t have sufficient manpower and sources.

Months in the past, being unwell evoked empathy; as we speak being unwell evokes concern. The concern of COVID-19? No! It is the concern of not gaining access to the care that you just want, the concern of absence of ventilators, the concern of a damaged well being system. It is the concern of loss of life. Our political leaders have stolen from the sick by corruption. Many Nigerian governors construct non-functional hospitals of their states. Usually, after the commissioning of those hospitals, all of the CT Scan, Magnetic Resonance Imaging (MRI) and different medical machines—a few of them faux—are returned to the place they have been bought or left to rot.

Hospitals in Nigeria are among the worst on this planet. Our educating hospitals at the moment are museums the place lower than 5% of medical trial and analysis is occurring due to poor laboratory. Medical tourism has due to this fact grow to be the norm. Dubai hospitals, Saudi Arabian hospitals, and so on., are promoting in Abuja and Lagos for Nigerian sufferers. They are recruiting Nigerian docs, together with consultants. Nigeria isn’t solely going through “brain drain,” we’re additionally going through “patient drain.” Our docs and nurses work within the worst situations. Hazard allowance for well being staff is about N5,000 whereas wardrobe allowance for members of the National Assembly runs into hundreds of thousands.

Now is the time for Nigeria to confront its healthcare disaster. The Nigerian authorities should settle for its failure. Our political leaders should brace as much as their duty and critically replicate on the issue their greed has delivered to Nigeria. This is the time to put money into a result-oriented healthcare system. Health is wealth because the saying goes. healthcare system is the muse of any nation.

If we survive COVID-19, we have to contemplate a legislation to limit all public officers from searching for medical care overseas. It could also be perceived as strict, however it can save future generations since we don’t know which pandemic would come subsequent and when.

Let’s give each Nigerian an area to stay and a not probability to die.

Runcie C.W. Chidebe is Executive Director, Project PINK BLUE. He is at the moment a Commonwealth Scholar on Transforming and Leading in Health Care at Birmingham City University, United Kingdom. He tweets @runciecwc

Opinion

AddThis

:

Original Author

:

Runcie C.W. Chidebe

Disable commercials

:

Read More
http://saharareporters.com/2020/04/03/nigeria%E2%80%99s-unhealthy-healthcare-eye-coronavirus-runcie-cw-chidebe

Views: 0

April 4, 2020
World TB Day 2020: It’s Time for solidarity
At this unique time in history when the world is grappling with the COVID-19 pandemic, the WHO Department of Global HIV, Hepatitis and STI Programmes stands in solidarity with governments and communities as they seek to maintain health services
and continue to address the needs of patients suffering from HIV and tuberculosis (TB).

Despite being preventable and treatable, tuberculosis remains the world’s biggest infectious killer and the leading cause of death among people living with HIV (PLHIV), responsible for 32% of the 770 000 lives lost to HIV in 2018. People
living with HIV are far more vulnerable (nearly 20 times more) to TB infection than people without HIV and are three times more likely to die during TB treatment.

While there are proven interventions that reduce TB deaths – such as provision of TB preventive treatment, adoption of novel diagnostics for earlier TB diagnosis and linkage to treatment, and antiretroviral therapy (ART) – we are far behind
in scaling these up, and diagnostic and treatment gaps remain, with only half of estimated TB cases among PLHIV reaching care in 2018, only half of estimated PLHIV with TB receiving ART, and less than half of PLHIV new on ART initiating TB preventive
treatment in a subset of countries which reported globally.

On this World TB Day, WHO highlights two key interventions to reduce unnecessary TB deaths among PLHIV:
- (1) provision of TB preventive treatment for all eligible PLHIV; and
- (2) increased uptake of newer diagnostic tests such as the lateral flow urine lipoarabinomannan assay (TB-LAM.)
As the new Director for the Department of Global HIV, Hepatitis and STI Programmes, I support current efforts to continue and to take to scale TB activities. It’s Time for solidarity!

-Meg Doherty, Director Global HIV, hepatitis and STI Programmes, WHO

HIV programmes are encouraged to ensure that TB preventive treatment, including shorter WHO-recommended regimens, with updated guidance launched today, are provided to all eligible PLHIV as part of a routine package of care, including provision of ART, and that treatment completion is ensured.

In recent months, WHO has also released guidelines for use of a bedside urine TB-LAM test to accelerate earlier TB diagnosis, with significantly expanded eligibility criteria. As this test is “point of care” with the potential for earlier
TB diagnosis and treatment initiation, HIV programmes should consider these recommendations as they enhance strategies for TB diagnosis among PLHIV, including as part of a routine package of advanced HIV care.

It’s Time to urgently scale up TB preventive treatment and TB diagnosis and strengthen referral and linkages to TB treatment at HIV service delivery points in all countries and continue to scale-up ART among PLHIV with TB. This applies to all populations
at risk, including children, pregnant women and marginalized groups, to ensure no one is left behind.

WHO calls for continued collaboration in countries across health programmes for harmonized and integrated policies and service delivery, and engagement with communities and other sectors. Unless HIV programmes scale up interventions to close these
gaps in prevention, diagnosis and treatment both for TB and HIV, countries and their development partners will not meet our common target: a 75% reduction in TB deaths among PLHIV between 2010 and 2020. HIV mortality cannot be reduced without addressing
the leading cause: tuberculosis.

Read More
https://www.who.int/news-room/detail/24-03-2020-world-tb-day-2020-it-s-time-for-solidarity

Views: 0
March 25, 2020
Most deaths due to late treatment: Dr Noor Hisham

PUTRAJAYA: Most of the Covid-19-related deaths in the country are due to late treatment, according to Health director-general Datuk Seri Dr Noor Hisham Abdullah (pix).

He said there were five stages of Covid-19 infection but most of them came to hospital when they were already at stage three.

“Stage one is where a person is asymptomatic but positive, while stage two is positive with mild symptom and stage three is when a patient has some form of pneumonia but does not require oxygen aid.

“In stage four, a patient will require oxygen therapy and the last stage (stage five) is when patients cannot breathe well and we need to intubate them and put them on ventilator,” he told a media briefing today.

Dr Noor Hisham also explained that in most stage four patients, their health would deteriorate fast to move to stage five.

“For example, the latest death, the patient already had breathing difficulty for the last three days,” he said.

He also said that besides late for treatment, age and comorbidities were also among factors that contributed to the Covid-19-related death.

“Some of the death cases had comorbidities and most of them were above 70 years old,” he said.

Meanwhile, Dr Noor Hisham said the MOH would enhance its case detection activities.

“It means we will find the case, we test the case, and if it is confirmed, we isolate the case and give treatment.

“We will continue to do our best to look into the focus group. For example, now we know that 60% of the infection are among the tabligh group. We will go and find them and test them,” he said, adding it was to ensure the individuals from the group would not infect others. – Bernama

Read More
https://www.thesundaily.my/local/most-deaths-due-to-late-treatment-dr-noor-hisham-HB2175988

Views: 0

March 24, 2020
New WHO recommendations to prevent tuberculosis aim to save millions of lives
Geneva – New World Health Organization (WHO) guidance will help countries accelerate efforts to stop people with tuberculosis (TB) infection becoming sick with TB by giving them preventive treatment.

A quarter of the world‘s population is estimated to be infected with TB bacteria. These people are neither sick nor contagious. However, they are at greater risk of developing TB disease, especially those with weakened immunity. Offering them TB
preventive treatment will not only protect them from becoming sick but also cut down on the risk of transmission in the community.

As we mark World TB Day 2020, the disease remains the world’s top infectious killer. In 2018, 10 million people fell ill with TB worldwide and 1.5 million people lost their lives to this disease.

“COVID-19 is highlighting just how vulnerable people with lung diseases and weakened immune systems can be,“ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “The world committed to end TB by 2030; improving prevention is key
to making this happen. Millions of people need to be able to take TB preventive treatment to stop the onset of disease, avert suffering and save lives”.

Dr Tedros highlighted the importance to continue efforts to tackle longstanding health problems, including TB during global outbreaks such as COVID-19. At the same time, programmes already in place to combat TB and other major infectious diseases
can be leveraged to make the response to COVID-19 more effective and rapid.

Although some progress has been made towards targets set at the UN high-level Meeting on TB in 2018, TB preventive treatment has been largely neglected. Global leaders committed to ensuring access to TB preventive treatment to at least 24 million contacts
of people with active TB and 6 million people living with HIV by 2022. To date only a fraction of that target has been reached, with countries putting less than 430,000 contacts and 1.8 million people on TB preventive treatment in 2018.

TB remains the top cause of death among people with HIV. TB preventive treatment works synergistically with antiretroviral therapy to prevent TB and save lives. Reinvigorated efforts by governments, health services, partners, donors and civil society
will be needed to increase access to TB preventive treatment to the levels targeted.

The new consolidated guidelines recommend a range of innovative approaches to scale up access to TB preventive treatment:
- WHO recommends a scale-up of TB preventive treatment among populations at highest risk including household contacts of TB patients, people living with HIV and other people at risk with lowered” immunity or living in crowded settings.
- WHO recommends an integration of TB preventive treatment services into ongoing case finding efforts for active TB. All household contacts of TB patients and people living with HIV are recommended to be screened
  for active TB. If active TB is ruled out, they should be initiated on TB preventive treatment.
- WHO recommends that either a tuberculin skin test or interferon-gamma release assay (IGRA) be used to test for TB infection. Both tests are helpful to find people more likely to benefit from TB preventive treatment
  but should not become a barrier to scale-up access. Testing for TB infection is not required before starting TB preventive treatment in people living with HIV, and children under 5 years who are contacts of people with active TB.
- WHO recommends new shorter options for preventive treatment in addition to the widely used 6 months of daily isoniazid. The shorter options that are now recommended range from a 1 month daily regimen of rifapentine plus isoniazid
  to 3 months weekly rifapentine plus isoniazid, 3 months daily rifampicin plus isoniazid, or 4 months of daily rifampicin alone.
“As people around the globe come together to commemorate World TB Day, WHO is calling on governments, affected communities, civil society organizations, health-care providers, donors, partners and the industry to unite forces and step up
the TB response – notably for TB preventive treatment – to ensure no one is left behind,” said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme. “The new WHO guidance shows the way forward for millions to rapidly
access new tools and shorter, safer options for preventive treatment. The time for action is now.”

TB preventive treatment is an affordable intervention that can prevent families from sliding into poverty and preserve the health and economy of whole communities. WHO anticipates that as new and safer drugs come onto the markets, and as prices
fall, it will become a highly-cost effective way to save millions of lives.

NOTES FOR EDITORS:

WORK BY WHO AND PARTNERS

WHO works closely with Member States including the US Government and technical and funding partners such as UNITAID to enhance access to shorter TB preventive treatment regimens. UNITAID-supported projects such as IMPAACT4TB and Cap-TB projects
enabled by WHO with partners in Brazil, Cambodia, Cameroon, Côte d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, India, Indonesia, Kenya, Lesotho, Malawi, Mozambique, South Africa, Uganda, United Republic of Tanzania and
Zimbabwe are leading the way. The new treatment options are also now more affordable, thanks to the significant price drop of rifapentine – a key drug – facilitated recently by UNITAID, the Global Fund to Fight AIDS, Tuberculosis and Malaria
and global biopharmaceutical company Sanofi, along with forthcoming arrangements underway with generic manufacturers.

MORE ABOUT THE GUIDELINES

The new consolidated WHO guidelines come with an operational handbook to help guide countries step-by-step as they take TB preventive treatment to scale. This includes guidance on how to prioritize and invest from demand creation for TB prevention
to supervision and monitoring of the programme.

The guidelines and operational handbook are also accompanied by an innovative mobile application – Prevent TB –to help health-care workers manage TB preventive treatment in their communities. Its online dashboard allows programme
managers to visualize and monitor data in real time. The application can be customized by countries to suit their specific settings and is currently being adopted in India and Philippines.

WORLD TB DAY

The new guidelines and tools are being released ahead of World TB Day. World TB Day is observed on March 24 each year to raise public awareness and understanding about the world’s deadliest infectious killer – TB and its devastating
health, social and economic impact on people around the world. Under the theme “It’s Time”, the spotlight this year is on urgently accelerating the TB response to save lives and end suffering.

Read More
https://www.who.int/news-room/detail/24-03-2020-new-who-recommendations-to-prevent-tuberculosis-aim-to-save-millions-of-lives

Views: 0
March 24, 2020
WHO teams with partners to mitigate the potential impact of the COVID-19 pandemic in malaria-affected areas
The rapid spread of COVID-19 is testing the resilience of robust health systems around the world. WHO and its partners are taking measures to mitigate the potential impact of sustained transmission of the coronavirus in malaria-endemic settings –
particularly in sub-Saharan Africa, which shoulders more than 90% of the global malaria burden.

To date, a small proportion of the global COVID-19 cases have been identified in malaria-affected countries. However, as of 17 March, 25 countries in the African Region had reported cases of COVID-19, and local transmission of the disease had been detected
in 6 countries (Algeria, Cameroon, Kenya, Rwanda, Senegal, South Africa).

“At this point, we still don’t know what the COVID-19 pandemic will look like in sub-Saharan Africa,” said Dr Pedro Alonso, Director of the WHO Global Malaria Programme. “But we do know that when public health emergencies have
hit parts of Africa with weak health systems and high malaria transmission, the impact on malaria disease and death has been very severe.”

The 2014-2016 Ebola outbreak in Guinea, Liberia and Sierra Leone, for example, undermined malaria control efforts and led to a massive increase in malaria-related illness and death in the 3 countries.

Joint action

To support malaria-affected countries, WHO has identified the need for a set of inter-related actions among global partners:
- generating, using and disseminating accurate information;
- mitigating against health system disruptions; and
- ensuring the continuity of routine malaria-specific interventions while also providing, where needed, additional emergency measures, such as mass drug administration, in health systems significantly impacted by COVID-19.
The Organization convened partners on 17 March to discuss areas of collaboration, coordination and next steps.

WHO has begun monitoring the evolving geographic location of COVID-19 cases to understand the extent to which the coronavirus and malaria affect the same target groups. This information will reveal who is likely to be at greatest risk, where and when,
and thus inform the need for malaria-specific interventions to save lives.

In parallel, WHO is working across the 3 levels of the organization to ensure that any advice intended to curb coronavirus transmission and to guide COVID-19 disease management is appropriate in malaria-affected settings.

In recent days, there have been reports of disruptions, as a result of COVID-19, in the production and global supply chains of essential malaria commodities, such as the long-lasting insecticidal nets, diagnostic testing and antimalarial medicines. Coordinated
efforts are required to ensure the availability of key malaria control tools – particularly in countries with a high burden of the disease – and that efforts to limit transmission of COVID-19 do not compromise access to malaria prevention,
diagnosis and treatment services.

Malaria-affected countries may also experience disruptions in health systems in the coming months. A marked increase in febrile patients seeking treatment for COVID-19 at health facilities, for example, would present a significant challenge for a health
workforce that may itself be depleted by the disease.

Policy guidance

WHO is developing guidance for national malaria control programmes and implementing partners to prepare them for the challenges they may face as result of COVID-19.  Among other areas, the guidance will address the mitigation of stockouts of
malaria medicines and commodities; the use of preventive malaria therapy for health workers; the deployment of emergency measures in some settings; and the generation of information relating to the geographic distribution and populations affected
by COVID-19 in malaria-endemic settings.

Restrictions around grouping people together – for training, social and behavior change communication activities, fixed-site distribution and clinical care – as well as the restrictions around movement of people in the country, will require
significant adaptations in order to deliver quality interventions and care.

All people living in malaria-affected areas are advised to follow same precautions as the general population, including: frequent hand-washing, respiratory hygiene, social distancing, seeking prompt medical care if symptoms arise (cough, fever,
difficulty breathing), and other WHO-recommended actions.

WHO stands ready to work with countries and other stakeholders to mitigate the negative impact of the coronavirus on malaria responses worldwide and, where possible, contribute towards a successful COVID-19 response.

About COVID-19

COVID-19 is the infectious disease caused by the most recently discovered coronavirus. This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019. Essential information on the COVID-19 pandemic can be found in
a dedicated WHO site.

About malaria

Malaria is a preventable and treatable disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. In 2018, there were an estimated 228 million cases of malaria worldwide and
405 000 malaria-related deaths. For more on malaria, visit: www.who.int/malaria

Read More
https://www.who.int/news-room/detail/18-03-2020-who-teams-with-partners-to-mitigate-the-potential-impact-of-the-covid-19-pandemic-in-malaria-affected-areas

Views: 0
March 19, 2020